Second biosimilar G-CSF approved in Japan
This article was originally published in Scrip
Executive Summary
Japan has granted regulatory approval to a second biosimilar recombinant granulocyte colony-stimulating factor (G-CSF) product, a move set to increase further the competitive pressure on branded original G-CSF preparations marketed in the country.